[go: up one dir, main page]

DK3319970T3 - Pyrido-oxazinonderivater som tnap-hæmmere - Google Patents

Pyrido-oxazinonderivater som tnap-hæmmere Download PDF

Info

Publication number
DK3319970T3
DK3319970T3 DK16775006T DK16775006T DK3319970T3 DK 3319970 T3 DK3319970 T3 DK 3319970T3 DK 16775006 T DK16775006 T DK 16775006T DK 16775006 T DK16775006 T DK 16775006T DK 3319970 T3 DK3319970 T3 DK 3319970T3
Authority
DK
Denmark
Prior art keywords
oxazino
pyrido
derivatives
tnap inhibitors
tnap
Prior art date
Application number
DK16775006T
Other languages
English (en)
Inventor
Shojiro Miyazaki
Yuko Yamamoto
Keisuke Suzuki
Masaharu Inui
Masanori Izumi
Kaori Soma
Anthony Pinkerton
Taeko Shinozaki
Original Assignee
Daiichi Sankyo Co Ltd
Sanford Burnham Prebys Medical Discovery Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd, Sanford Burnham Prebys Medical Discovery Inst filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of DK3319970T3 publication Critical patent/DK3319970T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK16775006T 2015-07-08 2016-07-07 Pyrido-oxazinonderivater som tnap-hæmmere DK3319970T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562190145P 2015-07-08 2015-07-08
PCT/US2016/041345 WO2017007943A1 (en) 2015-07-08 2016-07-07 Pyrido-oxazinone derivatives as tnap inhibitors

Publications (1)

Publication Number Publication Date
DK3319970T3 true DK3319970T3 (da) 2019-12-02

Family

ID=57045381

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16775006T DK3319970T3 (da) 2015-07-08 2016-07-07 Pyrido-oxazinonderivater som tnap-hæmmere

Country Status (28)

Country Link
US (3) US9920068B2 (da)
EP (1) EP3319970B1 (da)
JP (1) JP6666928B2 (da)
KR (1) KR102590067B1 (da)
CN (1) CN107207527B (da)
AU (1) AU2016291163B2 (da)
CA (1) CA2962795C (da)
CO (1) CO2017003830A2 (da)
CY (1) CY1122477T1 (da)
DK (1) DK3319970T3 (da)
ES (1) ES2754480T3 (da)
HR (1) HRP20192121T1 (da)
HU (1) HUE046994T2 (da)
IL (1) IL251005B (da)
LT (1) LT3319970T (da)
MX (1) MX2017003822A (da)
MY (1) MY185558A (da)
PH (1) PH12018500066A1 (da)
PL (1) PL3319970T3 (da)
PT (1) PT3319970T (da)
RS (1) RS59594B1 (da)
RU (1) RU2715704C2 (da)
SG (1) SG11201701378WA (da)
SI (1) SI3319970T1 (da)
SM (1) SMT201900666T1 (da)
TW (1) TWI702220B (da)
WO (1) WO2017007943A1 (da)
ZA (1) ZA201701783B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102480808B1 (ko) * 2016-12-23 2022-12-22 다이이찌 산쿄 가부시키가이샤 Tnap 저해 활성을 갖는 술폰아미드 화합물
WO2018119449A1 (en) * 2016-12-23 2018-06-28 Daiichi Sankyo Company, Limited Oxazepine derivatives having tnap inhibitory activity
WO2020086504A1 (en) * 2018-10-23 2020-04-30 Daiichi Sankyo Company, Limited Biaryl derivative
CN114085911B (zh) * 2022-01-19 2022-05-17 珠海圣美生物诊断技术有限公司 一种检测肿瘤细胞或肿瘤细胞碎片的方法
TW202513066A (zh) * 2023-09-25 2025-04-01 日商第一三共股份有限公司 製造n-吡啶基磺醯胺化合物之方法、吡啶化合物、及n-吡啶基磺醯胺化合物之結晶

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810795A (en) 1982-09-30 1989-03-07 A. H. Robins Company, Incorporated Certain 2,5 and 2,5,6-di- and tri-substituted nicotinic acid intermediates
AU1409100A (en) 1998-11-27 2000-06-19 Takeda Chemical Industries Ltd. Drugs
US6410520B2 (en) * 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US20110053910A1 (en) 2005-07-09 2011-03-03 Mckerrecher Darren 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
EP2433496A1 (en) 2007-05-08 2012-03-28 Burnham Institute for Medical Research Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
EP2817292B1 (en) 2012-02-22 2019-12-18 Sanford-Burnham Medical Research Institute Sulfonamide compounds and uses as tnap inhibitors

Also Published As

Publication number Publication date
US20170240562A1 (en) 2017-08-24
RU2017117179A (ru) 2019-08-08
HRP20192121T1 (hr) 2020-02-21
KR102590067B1 (ko) 2023-10-16
CN107207527A (zh) 2017-09-26
IL251005B (en) 2020-03-31
US9920068B2 (en) 2018-03-20
BR112017006798A2 (pt) 2018-01-09
WO2017007943A1 (en) 2017-01-12
CN107207527B (zh) 2019-10-01
EP3319970B1 (en) 2019-08-28
LT3319970T (lt) 2019-11-11
TW201713668A (zh) 2017-04-16
ZA201701783B (en) 2018-12-19
CY1122477T1 (el) 2021-01-27
PH12018500066A1 (en) 2018-07-09
KR20180028395A (ko) 2018-03-16
PL3319970T3 (pl) 2020-03-31
AU2016291163B2 (en) 2020-01-23
CA2962795A1 (en) 2017-01-12
SI3319970T1 (sl) 2019-12-31
ES2754480T3 (es) 2020-04-17
RS59594B1 (sr) 2020-01-31
NZ729387A (en) 2023-12-22
US20170210755A1 (en) 2017-07-27
RU2017117179A3 (da) 2019-09-24
JP2018522814A (ja) 2018-08-16
US9879032B2 (en) 2018-01-30
EP3319970A1 (en) 2018-05-16
CO2017003830A2 (es) 2017-08-31
TWI702220B (zh) 2020-08-21
HUE046994T2 (hu) 2020-04-28
PT3319970T (pt) 2019-11-15
MX2017003822A (es) 2017-06-26
US20180141960A1 (en) 2018-05-24
RU2715704C2 (ru) 2020-03-03
CA2962795C (en) 2019-09-10
HK1253572A1 (en) 2019-06-21
SMT201900666T1 (it) 2020-01-14
IL251005A0 (en) 2017-04-30
AU2016291163A1 (en) 2017-03-16
SG11201701378WA (en) 2018-01-30
US10221195B2 (en) 2019-03-05
MY185558A (en) 2021-05-20
JP6666928B2 (ja) 2020-03-18

Similar Documents

Publication Publication Date Title
IL263586A (en) Inhibitors of the menin-mll interaction
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3302448T3 (da) Erstattede heterocyclylafledninger som cdk-inhibitore
LT3303334T (lt) Tirozinkinazės inhibitoriai
DK3298002T3 (da) Heterocykliske amider som kinasehæmmere
DK3105218T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3105226T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3377488T3 (da) Heterocykliske forbindelser som immunomodulatorer
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3786162T3 (da) Bipyrazolderivater som jak-inhibitorer
HUE042335T2 (hu) ROR-gamma dihidropirrolopiridin inhibitorai
DK3442972T3 (da) Bromdomænehæmmere
DK3204381T3 (da) N-pyridinylacetamidderivater som wnt-signaleringsbanehæmmere
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
DK3313832T3 (da) 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere
DK3094631T4 (da) Pyrimidinyloxybenzenderivater som herbicider
DK3286177T3 (da) Quinolinderivater som tam rtk-inhibitorer
DK3288944T3 (da) Imidazopyrazinoner som pde1-inhibitorer
DK3341379T3 (da) EZH2-hæmmere
DK3116475T3 (da) Dopa-decarboxylasehæmmersammensætninger
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer
DK3458460T3 (da) Imidazoler som histondemethylase-inhibitorer